BAX vs. IBB
Compare and contrast key facts about Baxter International Inc. (BAX) and iShares Nasdaq Biotechnology ETF (IBB).
IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BAX or IBB.
Performance
BAX vs. IBB - Performance Comparison
Returns By Period
In the year-to-date period, BAX achieves a -12.57% return, which is significantly lower than IBB's -1.84% return. Over the past 10 years, BAX has underperformed IBB with an annualized return of -0.09%, while IBB has yielded a comparatively higher 3.30% annualized return.
BAX
-12.57%
-10.42%
-4.16%
-3.92%
-15.03%
-0.09%
IBB
-1.84%
-8.82%
-3.12%
13.02%
3.43%
3.30%
Key characteristics
| BAX | IBB | |
|---|---|---|
| Sharpe Ratio | -0.15 | 0.78 |
| Sortino Ratio | -0.02 | 1.18 |
| Omega Ratio | 1.00 | 1.14 |
| Calmar Ratio | -0.06 | 0.43 |
| Martin Ratio | -0.29 | 3.66 |
| Ulcer Index | 13.55% | 3.83% |
| Daily Std Dev | 26.53% | 17.93% |
| Max Drawdown | -68.27% | -62.85% |
| Current Drawdown | -61.52% | -23.79% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BAX and IBB is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
BAX vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Baxter International Inc. (BAX) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BAX vs. IBB - Dividend Comparison
BAX's dividend yield for the trailing twelve months is around 3.51%, more than IBB's 0.34% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAX Baxter International Inc. | 3.51% | 3.00% | 2.26% | 1.26% | 1.19% | 1.02% | 1.11% | 0.94% | 1.14% | 2.08% | 2.80% | 2.76% |
IBB iShares Nasdaq Biotechnology ETF | 0.34% | 0.26% | 0.31% | 0.21% | 0.20% | 0.17% | 0.19% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
BAX vs. IBB - Drawdown Comparison
The maximum BAX drawdown since its inception was -68.27%, which is greater than IBB's maximum drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for BAX and IBB. For additional features, visit the drawdowns tool.
Volatility
BAX vs. IBB - Volatility Comparison
Baxter International Inc. (BAX) has a higher volatility of 7.42% compared to iShares Nasdaq Biotechnology ETF (IBB) at 7.05%. This indicates that BAX's price experiences larger fluctuations and is considered to be riskier than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.